ELIAS Animal Health Blog
Read the latest news and updates from ELIAS Animal Health
Philip J. Bergman, DVM, PhD, DACVIM (Oncology) Joins ELIAS Animal Health Scientific Advisory Board
LENEXA, Kan., April 10, 2025 -- ELIAS Animal Health, a leading innovator in cancer immunotherapies for veterinary medicine, today announced [...]
ELIAS Animal Health Receives Full Approval from USDA for the ELIAS Cancer Immunotherapy (ECI®), First-In-Class Treatment for Canine Osteosarcoma
LENEXA, Kan., Mar. 19, 2025 -- ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced its adoptive [...]
ELIAS Animal Health Announces Apheresis Partnership with CTAC, Expanding Access to Cancer Immunotherapy in Southeast U.S.
LENEXA, Kan., Feb. 13, 2025 -- In alignment with our commitment to expand access to innovative veterinary cancer care across [...]
ELIAS Animal Health Conducting Limb-Sparing Canine Osteosarcoma Clinical Study with Grant from Morris Animal Foundation
LENEXA, Kan., July 31, 2024 /PRNewswire/ -- ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer [...]
ELIAS Animal Health Expands Manufacturing Capacity Ahead of Product Approval and Pipeline Expansion
OLATHE, Kan., April 30, 2024 /PRNewswire/ -- ELIAS Animal Health, a leading companion animal cancer therapeutics company, is expanding its [...]
ELIAS Animal Health Appoints Chief Revenue Officer; Launches Fundraising Round to Support Commercialization and Development of Innovative Canine Cancer Therapies
Experienced executive will lead launch of the first USDA-approved immunotherapy for the treatment of bone cancer in dogs OLATHE, Kan., [...]
PODCAST: ELIAS returns to Dog Cancer Answers to Talk About Alternatives to Chemotherapy
ELIAS Animal Health CEO, Tammie Wahaus, returns to the Dog Cancer Answers podcast to talk about ECI® as an alternative [...]